Want to join the conversation?
For 2016, $HCN expects net income attributable to common stockholders to be in the range of $2.04-2.14 per diluted share; FFO to be in the range of $4.50-4.60 per diluted share, representing a 3-5% increase; and FAD to be in the range of $3.95-4.05 per diluted share, representing a 3-5% increase.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?